Effects of External Application of Chinese Medicine on Diabetic Ulcers and the Expressions of β-catenin,c-myc and K6

Objective:To observe the clinical efficacy of Chinese medicine(CM) treatment of Hongyou Ointment(红油膏) and Shengji Powder(生肌散) on diabetic ulcers,and to observe the influence of CM treatment on the expressions of proteins associated with the Wnt signaling pathway,such asβ-catenin,c-myc and K6.Methods...

Full description

Saved in:
Bibliographic Details
Published inChinese journal of integrative medicine Vol. 17; no. 4; pp. 261 - 266
Main Author 李福伦 邓辉 王宏伟 徐蓉 陈洁 王一飞 李欣 范斌 李斌
Format Journal Article
LanguageEnglish
Published Heidelberg Chinese Association of Traditional and Western Medicine 01.04.2011
Subjects
Online AccessGet full text
ISSN1672-0415
1993-0402
1993-0402
DOI10.1007/s11655-011-0703-5

Cover

Abstract Objective:To observe the clinical efficacy of Chinese medicine(CM) treatment of Hongyou Ointment(红油膏) and Shengji Powder(生肌散) on diabetic ulcers,and to observe the influence of CM treatment on the expressions of proteins associated with the Wnt signaling pathway,such asβ-catenin,c-myc and K6.Methods:sixty-two patients fitting the registration standards were randomly divided into the CM group(31 patients) and the Western medicine(WM) group(31 patients) by a random number table.The patients in the CM group were treated with Hongyou Ointment and Shengji Powder externally.The patients in the WM group were treated with mupirocin ointment,growth factor(bFGF),and Vaseline gauze for external use and with basic therapies.Wound-healing time and four-week healing rate were recorded.The wounds were measured by digital photography and ImageJ software.Skin biopsies were obtained from 24 patients before CM treatment and 20 patients after CM treatment.Immunohistochemical tests and semi-quantitative imaging with NIH ImageJ 1.42 software were used to analyze the changes in protein expression ofβ-catenin,c-myc,and K6.Results:Fifty-three patients completed the trial;four patients in the CM treatment group and five patients in the WM group dropped out.Among them,four were dissatisfied with the treatment process,two could not continue because of their jobs,two failed to complete the course of follow-up appointments,and one was diagnosed with squamous cell carcinoma during treatment.The comparison of ulcer healing rates between the two groups showed insignificant differences(P=0.77).The ulcer healing rates were 33.33%(9/27) in the CM group and 26.92%(7/26) in the WM group.However,the effective rate was significantly higher in the CM group(81.48%,22/27) than in the WM group(57.69%,15/26,P=0.04).The mean wound healing time was shorter in the CM group(22.71±5.46 days) than in the WM group(26.56±7.56 days,P=0.04).CM treatment was well tolerated,and there was no withdrawal due to adverse reactions.Immunohistochemical analysis in the refractory wound indicated higher expressions ofβ-catenin,c-myc and K6 compared with the normal skin.β-catenin was abnormally expressed in the nuclei of the keratinocytes and fibroblasts at the wound margins,and the expressions of c-myc and K6 were highly expressed in the full hyperplastic epidermis,especially in the granular layer(P0.05).The expressions of these proteins decreased after CM treatment.The expression levels ofβ-catenin,c-myc,and K6 proteins before and after the treatment were 101.88±10.76 vs.140.42±8.45;113.27±16.75 vs.153.79±8.32; 90.39±11.07 vs.151.29±7.39,respectively.Conclusions:CM treatment using Hongyou Ointment and Shengji Powder was efficient in the management of diabetic skin ulcers.The mechanism of action might be related to the inhibition of the Wnt signaling pathway.
AbstractList Objective To observe the clinical efficacy of Chinese medicine (CM) treatment of Hongyou Ointment (红油膏) and Shengji Powder (生肌散) on diabetic ulcers, and to observe the influence of CM treatment on the expressions of proteins associated with the Wnt signaling pathway, such as β-catenin, c-myc and K6. Methods sixty-two patients fitting the registration standards were randomly divided into the CM group (31 patients) and the Western medicine (WM) group (31 patients) by a random number table. The patients in the CM group were treated with Hongyou Ointment and Shengji Powder externally. The patients in the WM group were treated with mupirocin ointment, growth factor (bFGF), and Vaseline gauze for external use and with basic therapies. Wound-healing time and four-week healing rate were recorded. The wounds were measured by digital photography and ImageJ software. Skin biopsies were obtained from 24 patients before CM treatment and 20 patients after CM treatment. Immunohistochemical tests and semi-quantitative imaging with NIH ImageJ 1.42 software were used to analyze the changes in protein expression of β-catenin, c-myc, and K6. Results Fifty-three patients completed the trial; four patients in the CM treatment group and five patients in the WM group dropped out. Among them, four were dissatisfied with the treatment process, two could not continue because of their jobs, two failed to complete the course of follow-up appointments, and one was diagnosed with squamous cell carcinoma during treatment. The comparison of ulcer healing rates between the two groups showed insignificant differences ( P =0.77). The ulcer healing rates were 33.33% (9/27) in the CM group and 26.92% (7/26) in the WM group. However, the effective rate was significantly higher in the CM group (81.48%, 22/27) than in the WM group (57.69%, 15/26, P =0.04). The mean wound healing time was shorter in the CM group (22.71 ±5.46 days) than in the WM group (26.56 ±7.56 days, P =0.04). CM treatment was well tolerated, and there was no withdrawal due to adverse reactions. Immunohistochemical analysis in the refractory wound indicated higher expressions of β-catenin, c-myc and K6 compared with the normal skin. β-catenin was abnormally expressed in the nuclei of the keratinocytes and fibroblasts at the wound margins, and the expressions of c-myc and K6 were highly expressed in the full hyperplastic epidermis, especially in the granular layer ( P <0.05). The expressions of these proteins decreased after CM treatment. The expression levels of β-catenin, c-myc, and K6 proteins before and after the treatment were 101.88 ± 10.76 vs. 140.42 ±8.45; 113.27 ± 16.75 vs. 153.79 ±8.32; 90.39 ±11.07 vs. 151.29 ±7.39, respectively. Conclusions CM treatment using Hongyou Ointment and Shengji Powder was efficient in the management of diabetic skin ulcers. The mechanism of action might be related to the inhibition of the Wnt signaling pathway.
To observe the clinical efficacy of Chinese medicine (CM) treatment of Hongyou Ointment and Shengji Powder on diabetic ulcers, and to observe the influence of CM treatment on the expressions of proteins associated with the Wnt signaling pathway, such as β-catenin, c-myc and K6.OBJECTIVETo observe the clinical efficacy of Chinese medicine (CM) treatment of Hongyou Ointment and Shengji Powder on diabetic ulcers, and to observe the influence of CM treatment on the expressions of proteins associated with the Wnt signaling pathway, such as β-catenin, c-myc and K6.sixty-two patients fitting the registration standards were randomly divided into the CM group (31 patients) and the Western medicine (WM) group (31 patients) by a random number table. The patients in the CM group were treated with Hongyou Ointment and Shengji Powder externally. The patients in the WM group were treated with mupirocin ointment, growth factor (bFGF), and Vaseline gauze for external use and with basic therapies. Wound-healing time and four-week healing rate were recorded. The wounds were measured by digital photography and ImageJ software. Skin biopsies were obtained from 24 patients before CM treatment and 20 patients after CM treatment. Immunohistochemical tests and semi-quantitative imaging with NIH ImageJ 1.42 software were used to analyze the changes in protein expression of β-catenin, c-myc, and K6.METHODSsixty-two patients fitting the registration standards were randomly divided into the CM group (31 patients) and the Western medicine (WM) group (31 patients) by a random number table. The patients in the CM group were treated with Hongyou Ointment and Shengji Powder externally. The patients in the WM group were treated with mupirocin ointment, growth factor (bFGF), and Vaseline gauze for external use and with basic therapies. Wound-healing time and four-week healing rate were recorded. The wounds were measured by digital photography and ImageJ software. Skin biopsies were obtained from 24 patients before CM treatment and 20 patients after CM treatment. Immunohistochemical tests and semi-quantitative imaging with NIH ImageJ 1.42 software were used to analyze the changes in protein expression of β-catenin, c-myc, and K6.Fifty-three patients completed the trial; four patients in the CM treatment group and five patients in the WM group dropped out. Among them, four were dissatisfied with the treatment process, two could not continue because of their jobs, two failed to complete the course of follow-up appointments, and one was diagnosed with squamous cell carcinoma during treatment. The comparison of ulcer healing rates between the two groups showed insignificant differences (P=0.77). The ulcer healing rates were 33.33% (9/27) in the CM group and 26.92% (7/26) in the WM group. However, the effective rate was significantly higher in the CM group (81.48%, 22/27) than in the WM group (57.69%, 15/26, P=0.04). The mean wound healing time was shorter in the CM group (22.71 ±5.46 days) than in the WM group (26.56 ±7.56 days, P=0.04). CM treatment was well tolerated, and there was no withdrawal due to adverse reactions. Immunohistochemical analysis in the refractory wound indicated higher expressions of β-catenin, c-myc and K6 compared with the normal skin. β-catenin was abnormally expressed in the nuclei of the keratinocytes and fibroblasts at the wound margins, and the expressions of c-myc and K6 were highly expressed in the full hyperplastic epidermis, especially in the granular layer (P<0.05). The expressions of these proteins decreased after CM treatment. The expression levels of β-catenin, c-myc, and K6 proteins before and after the treatment were 101.88 ± 10.76 vs. 140.42 ±8.45; 113.27 ± 16.75 vs. 153.79 ±8.32; 90.39 ±11.07 vs. 151.29 ±7.39, respectively.RESULTSFifty-three patients completed the trial; four patients in the CM treatment group and five patients in the WM group dropped out. Among them, four were dissatisfied with the treatment process, two could not continue because of their jobs, two failed to complete the course of follow-up appointments, and one was diagnosed with squamous cell carcinoma during treatment. The comparison of ulcer healing rates between the two groups showed insignificant differences (P=0.77). The ulcer healing rates were 33.33% (9/27) in the CM group and 26.92% (7/26) in the WM group. However, the effective rate was significantly higher in the CM group (81.48%, 22/27) than in the WM group (57.69%, 15/26, P=0.04). The mean wound healing time was shorter in the CM group (22.71 ±5.46 days) than in the WM group (26.56 ±7.56 days, P=0.04). CM treatment was well tolerated, and there was no withdrawal due to adverse reactions. Immunohistochemical analysis in the refractory wound indicated higher expressions of β-catenin, c-myc and K6 compared with the normal skin. β-catenin was abnormally expressed in the nuclei of the keratinocytes and fibroblasts at the wound margins, and the expressions of c-myc and K6 were highly expressed in the full hyperplastic epidermis, especially in the granular layer (P<0.05). The expressions of these proteins decreased after CM treatment. The expression levels of β-catenin, c-myc, and K6 proteins before and after the treatment were 101.88 ± 10.76 vs. 140.42 ±8.45; 113.27 ± 16.75 vs. 153.79 ±8.32; 90.39 ±11.07 vs. 151.29 ±7.39, respectively.CM treatment using Hongyou Ointment and Shengji Powder was efficient in the management of diabetic skin ulcers. The mechanism of action might be related to the inhibition of the Wnt signaling pathway.CONCLUSIONSCM treatment using Hongyou Ointment and Shengji Powder was efficient in the management of diabetic skin ulcers. The mechanism of action might be related to the inhibition of the Wnt signaling pathway.
Objective:To observe the clinical efficacy of Chinese medicine(CM) treatment of Hongyou Ointment(红油膏) and Shengji Powder(生肌散) on diabetic ulcers,and to observe the influence of CM treatment on the expressions of proteins associated with the Wnt signaling pathway,such asβ-catenin,c-myc and K6.Methods:sixty-two patients fitting the registration standards were randomly divided into the CM group(31 patients) and the Western medicine(WM) group(31 patients) by a random number table.The patients in the CM group were treated with Hongyou Ointment and Shengji Powder externally.The patients in the WM group were treated with mupirocin ointment,growth factor(bFGF),and Vaseline gauze for external use and with basic therapies.Wound-healing time and four-week healing rate were recorded.The wounds were measured by digital photography and ImageJ software.Skin biopsies were obtained from 24 patients before CM treatment and 20 patients after CM treatment.Immunohistochemical tests and semi-quantitative imaging with NIH ImageJ 1.42 software were used to analyze the changes in protein expression ofβ-catenin,c-myc,and K6.Results:Fifty-three patients completed the trial;four patients in the CM treatment group and five patients in the WM group dropped out.Among them,four were dissatisfied with the treatment process,two could not continue because of their jobs,two failed to complete the course of follow-up appointments,and one was diagnosed with squamous cell carcinoma during treatment.The comparison of ulcer healing rates between the two groups showed insignificant differences(P=0.77).The ulcer healing rates were 33.33%(9/27) in the CM group and 26.92%(7/26) in the WM group.However,the effective rate was significantly higher in the CM group(81.48%,22/27) than in the WM group(57.69%,15/26,P=0.04).The mean wound healing time was shorter in the CM group(22.71±5.46 days) than in the WM group(26.56±7.56 days,P=0.04).CM treatment was well tolerated,and there was no withdrawal due to adverse reactions.Immunohistochemical analysis in the refractory wound indicated higher expressions ofβ-catenin,c-myc and K6 compared with the normal skin.β-catenin was abnormally expressed in the nuclei of the keratinocytes and fibroblasts at the wound margins,and the expressions of c-myc and K6 were highly expressed in the full hyperplastic epidermis,especially in the granular layer(P0.05).The expressions of these proteins decreased after CM treatment.The expression levels ofβ-catenin,c-myc,and K6 proteins before and after the treatment were 101.88±10.76 vs.140.42±8.45;113.27±16.75 vs.153.79±8.32; 90.39±11.07 vs.151.29±7.39,respectively.Conclusions:CM treatment using Hongyou Ointment and Shengji Powder was efficient in the management of diabetic skin ulcers.The mechanism of action might be related to the inhibition of the Wnt signaling pathway.
To observe the clinical efficacy of Chinese medicine (CM) treatment of Hongyou Ointment and Shengji Powder on diabetic ulcers, and to observe the influence of CM treatment on the expressions of proteins associated with the Wnt signaling pathway, such as β-catenin, c-myc and K6. sixty-two patients fitting the registration standards were randomly divided into the CM group (31 patients) and the Western medicine (WM) group (31 patients) by a random number table. The patients in the CM group were treated with Hongyou Ointment and Shengji Powder externally. The patients in the WM group were treated with mupirocin ointment, growth factor (bFGF), and Vaseline gauze for external use and with basic therapies. Wound-healing time and four-week healing rate were recorded. The wounds were measured by digital photography and ImageJ software. Skin biopsies were obtained from 24 patients before CM treatment and 20 patients after CM treatment. Immunohistochemical tests and semi-quantitative imaging with NIH ImageJ 1.42 software were used to analyze the changes in protein expression of β-catenin, c-myc, and K6. Fifty-three patients completed the trial; four patients in the CM treatment group and five patients in the WM group dropped out. Among them, four were dissatisfied with the treatment process, two could not continue because of their jobs, two failed to complete the course of follow-up appointments, and one was diagnosed with squamous cell carcinoma during treatment. The comparison of ulcer healing rates between the two groups showed insignificant differences (P=0.77). The ulcer healing rates were 33.33% (9/27) in the CM group and 26.92% (7/26) in the WM group. However, the effective rate was significantly higher in the CM group (81.48%, 22/27) than in the WM group (57.69%, 15/26, P=0.04). The mean wound healing time was shorter in the CM group (22.71 ±5.46 days) than in the WM group (26.56 ±7.56 days, P=0.04). CM treatment was well tolerated, and there was no withdrawal due to adverse reactions. Immunohistochemical analysis in the refractory wound indicated higher expressions of β-catenin, c-myc and K6 compared with the normal skin. β-catenin was abnormally expressed in the nuclei of the keratinocytes and fibroblasts at the wound margins, and the expressions of c-myc and K6 were highly expressed in the full hyperplastic epidermis, especially in the granular layer (P<0.05). The expressions of these proteins decreased after CM treatment. The expression levels of β-catenin, c-myc, and K6 proteins before and after the treatment were 101.88 ± 10.76 vs. 140.42 ±8.45; 113.27 ± 16.75 vs. 153.79 ±8.32; 90.39 ±11.07 vs. 151.29 ±7.39, respectively. CM treatment using Hongyou Ointment and Shengji Powder was efficient in the management of diabetic skin ulcers. The mechanism of action might be related to the inhibition of the Wnt signaling pathway.
Author 李福伦 邓辉 王宏伟 徐蓉 陈洁 王一飞 李欣 范斌 李斌
AuthorAffiliation Yueyang Hospital of Integrated Traditional Chinese andWestern Medicine, Affiliated to Shanghai University ofTraditional Chinese Medicine, Shanghai (200437), China The Sixth Hospital Affiliated Shanghai Jiaotong University, Shanghai(200233), China Shanghai Skin Diseases and Sexually Transmitled Diseases Hospital, Shanghai (200050), China.
Author_xml – sequence: 1
  fullname: 李福伦 邓辉 王宏伟 徐蓉 陈洁 王一飞 李欣 范斌 李斌
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21509668$$D View this record in MEDLINE/PubMed
BookMark eNp9kctu1DAUhi3Uil7gAdigiA0b0voy9kmW1TBcRCs2dG05nuOOS8ZJbUdqX4sH4ZlwZqYbFl356Oj7P0vnPyNHYQhIyDtGLxilcJkYU1LWlLGaAhW1fEVOWduKmi4oPyqzAl5mJk_IWUr3lEpQVL4mJ5xJ2irVnJJp5RzanKrBVavHjDGYvroax95bk_0Q5v1y4wMmrG5w7W0Zq7L-7E2H2dvqtrcYU2XCusobLI4xYkoluVP-_VMXDwYfPtl6-2R33A_1hhw70yd8e3jPye2X1a_lt_r659fvy6vr2gqguW45cx130DUtBQ5mwayyCABOWUBQ3EmLlLbSrDvAhi0ksIKKhjeoBOvEOfm4945xeJgwZb31yWLfm4DDlHSjxII3ALKQ7w_k1G1xrcfotyY-6edLFQD2gI1DShGdtj7vTpSj8b1mVM-d6H0nunSi5070rGb_JZ_lL2X4PpMKG-4w6vthmrtJL4Y-HD7aDOHuoeR0Z-xv53vUApRqG9GKf-g8qH0
CitedBy_id crossref_primary_10_3389_fphar_2021_726158
crossref_primary_10_1155_2012_930192
crossref_primary_10_1155_2019_8450397
crossref_primary_10_1186_s12906_017_2074_8
crossref_primary_10_1016_j_addr_2023_114764
crossref_primary_10_1016_j_bbrc_2024_150235
crossref_primary_10_1016_j_jep_2021_114845
crossref_primary_10_3389_fphar_2024_1288479
crossref_primary_10_1155_2020_5091671
crossref_primary_10_4239_wjd_v14_i1_1
crossref_primary_10_1016_j_jep_2020_113643
crossref_primary_10_1002_14651858_CD011038_pub2
crossref_primary_10_4236_ojgas_2017_712032
crossref_primary_10_1016_j_ctim_2019_03_007
crossref_primary_10_1016_j_jep_2022_115954
crossref_primary_10_1371_journal_pone_0132104
crossref_primary_10_1007_s11655_016_2604_0
crossref_primary_10_1155_2012_956107
crossref_primary_10_1186_s12906_023_03894_0
crossref_primary_10_1016_j_jep_2024_117938
Cites_doi 10.1073/pnas.102657399
10.1016/j.jamcollsurg.2009.04.012
10.1097/WON.0b013e3181bfdd1a
10.1046/j.1524-475X.2002.10603.x
10.1038/nature05766
10.1097/01.WON.0000319125.21854.78
10.1172/JCI32169
10.1016/S0002-9440(10)62953-7
10.1097/01.ASW.0000343730.76308.6a
10.1097/01.ASW.0000323563.59885.1c
10.1016/j.jss.2006.07.026
10.2337/diacare.27.10.2568
10.2119/2006-00054.Vittorini
10.3736/jcim20050314
10.1097/WON.0b013e3181bfdf83
10.2337/diacare.22.1.157
10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
10.1186/1471-2121-10-38
ContentType Journal Article
Copyright Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2011
Copyright_xml – notice: Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2011
DBID 2RA
92L
CQIGP
W95
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s11655-011-0703-5
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-农业科学
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Effects of External Application of Chinese Medicine on Diabetic Ulcers and the Expressions of β-catenin,c-myc and K6
EISSN 1993-0402
EndPage 266
ExternalDocumentID 21509668
10_1007_s11655_011_0703_5
37669839
Genre Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29B
29~
2B.
2C~
2J2
2JN
2JY
2KG
2KM
2LR
2RA
2VQ
2~H
30V
36B
4.4
406
408
40D
40E
5GY
5VR
5VS
6NX
6PF
92F
92I
92L
93N
93R
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
ABDZT
ABECU
ABFGW
ABFTV
ABHQN
ABJOX
ABKAS
ABKCH
ABMNI
ABMQK
ABNWP
ABQBU
ABSXP
ABTEG
ABTMW
ABXPI
ACBMV
ACBRV
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACSNA
ACTTH
ACUDM
ACVWB
ACWMK
ADHIR
ADINQ
ADKNI
ADKPE
ADMDM
ADRFC
ADTIX
ADURQ
ADYFF
ADZKW
AEBTG
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESTI
AETLH
AEVTX
AEXYK
AFLOW
AFQWF
AFUIB
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMYLF
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BGNMA
CAG
CCEZO
CDYEO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
DNIVK
DU5
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
ESBYG
F5P
FA0
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GRRUI
H13
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IPNFZ
ITM
I~X
I~Z
J-C
JBSCW
JZLTJ
LLZTM
M4Y
MA-
NDZJH
NQJWS
NU0
O9-
P9S
PF0
PT4
QOR
QOS
R89
R9I
ROL
RPX
RSV
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCL
SCLPG
SDH
SHX
SISQX
SMD
SNE
SNX
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SV3
SZ9
SZN
T13
T16
TCJ
TGQ
TSG
TT1
TUC
U2A
U9L
UG4
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
W95
WFFXF
WK8
YLTOR
Z7U
ZMTXR
ZOVNA
~A9
~WA
-SE
-S~
AACDK
AAJBT
AASML
AATNV
AAXDM
AAYZH
ABAKF
ABJNI
ABQSL
ABTKH
ABWNU
ACAOD
ACDTI
ACPIV
ACZOJ
ADTPH
AEFQL
AEMSY
AESKC
AEVLU
AFBBN
AGQEE
AGRTI
AIGIU
AMXSW
AOCGG
CAJEE
DDRTE
DPUIP
IKXTQ
IWAJR
NPVJJ
Q--
SJYHP
SNPRN
SOHCF
U1G
U5O
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c370t-921fb2f7b890727a41c6ce777f6c7e762f5ce0095adb7e8145718903828e631b3
IEDL.DBID U2A
ISSN 1672-0415
1993-0402
IngestDate Fri Sep 05 09:36:06 EDT 2025
Wed Feb 19 01:50:07 EST 2025
Wed Oct 01 01:53:38 EDT 2025
Thu Apr 24 23:09:08 EDT 2025
Fri Feb 21 02:35:56 EST 2025
Fri Nov 25 18:20:37 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords external application
β-catenin
Chinese medicine
c-myc
diabetic foot
K6
proto-oncogene proteins
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c370t-921fb2f7b890727a41c6ce777f6c7e762f5ce0095adb7e8145718903828e631b3
Notes external application
β-catenin
diabetic foot; Chinese medicine; external application; proto-oncogene proteins; β-catenin; c-myc; K6
Chinese medicine
c-myc
diabetic foot
S943.325
11-4928/R
K6
proto-oncogene proteins
TQ460.4
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 21509668
PQID 863428775
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_863428775
pubmed_primary_21509668
crossref_citationtrail_10_1007_s11655_011_0703_5
crossref_primary_10_1007_s11655_011_0703_5
springer_journals_10_1007_s11655_011_0703_5
chongqing_backfile_37669839
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-04-01
PublicationDateYYYYMMDD 2011-04-01
PublicationDate_xml – month: 04
  year: 2011
  text: 2011-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Heidelberg
PublicationPlace_xml – name: Heidelberg
– name: China
PublicationTitle Chinese journal of integrative medicine
PublicationTitleAbbrev Chin. J. Integr. Med
PublicationTitleAlternate Chinese Journal of Integrative Medicine
PublicationYear 2011
Publisher Chinese Association of Traditional and Western Medicine
Publisher_xml – name: Chinese Association of Traditional and Western Medicine
References Xu, Li, Xiao, Gu, Fan, Li (CR21) 2006; 12
Xiao, Wang, Fan, Li, Xu, Xu (CR22) 2005; 4
Brem, Stojadinovic, Diegelmann, Entero, Lee, Pastar (CR13) 2007; 13
Saap, Falanga (CR14) 2002; 10
CR3
Rathmann, Giani (CR1) 2004; 27
Ramundo, Gray (CR17) 2009; 36
Bowley, O’Gorman, Gan (CR6) 2007; 138
Steed, Donohoe, Webster, Lindsley (CR15) 1996; 183
Alberti, Zimmet (CR2) 1998; 15
Stojadinovic, Brem, Vouthounis, Lee, Fallon, Stallcup (CR8) 2005; 167
Tomic-Canic, Ayello, Stojadinovic, Golinko, Brem (CR12) 2008; 21
Poon, Nik, Ahn, Slade, Alman (CR20) 2009; 5
Golinko, Joffe, de Vinck, Chandrasekaran, Stojadinovic, Barrientos (CR11) 2009; 209
Li, Wang, Xiao, Li, Fan (CR23) 2005; 3
Hunter, Langemo, Thompson, Hanson, Anderson (CR19) 2009; 22
Ito, Yang, Andl, Cui, Kim, Millar (CR9) 2007; 447
Brem, Tomic-Canic (CR10) 2007; 117
Shi, Carson (CR18) 2009; 36
Li, Li, Wang, Fan, Xu, Jing (CR24) 2008; 49
Reiber, Vileikyte, Boyko, del Aguila, Smith, Lavery (CR4) 1999; 22
Ramundo, Gray (CR16) 2008; 35
Fu (CR5) 2004; 20
Cheon, Cheah, Turley, Nadesan, Poon, Clevers (CR7) 2002; 99
M. Ito (703_CR9) 2007; 447
X.B. Fu (703_CR5) 2004; 20
M.S. Golinko (703_CR11) 2009; 209
S.S. Cheon (703_CR7) 2002; 99
703_CR3
L. Shi (703_CR18) 2009; 36
K.G. Alberti (703_CR2) 1998; 15
D.L. Steed (703_CR15) 1996; 183
J. Ramundo (703_CR17) 2009; 36
S. Hunter (703_CR19) 2009; 22
W.B. Xu (703_CR21) 2006; 12
X.L. Xiao (703_CR22) 2005; 4
E. Bowley (703_CR6) 2007; 138
M. Tomic-Canic (703_CR12) 2008; 21
H. Brem (703_CR13) 2007; 13
R. Poon (703_CR20) 2009; 5
G.E. Reiber (703_CR4) 1999; 22
B. Li (703_CR24) 2008; 49
W. Rathmann (703_CR1) 2004; 27
O. Stojadinovic (703_CR8) 2005; 167
L.J. Saap (703_CR14) 2002; 10
B. Li (703_CR23) 2005; 3
H. Brem (703_CR10) 2007; 117
J. Ramundo (703_CR16) 2008; 35
15885172 - Zhong Xi Yi Jie He Xue Bao. 2005 May;3(3):216-9
12453138 - Wound Repair Regen. 2002 Nov-Dec;10(6):354-9
19096281 - Adv Skin Wound Care. 2009 Jan;22(1):25-7
18836328 - Adv Skin Wound Care. 2008 Oct;21(10):487-92; quiz 493-4
17476353 - J Clin Invest. 2007 May;117(5):1219-22
19432963 - BMC Cell Biol. 2009 May 11;10:38
11983872 - Proc Natl Acad Sci U S A. 2002 May 14;99(10):6973-8
19918148 - J Wound Ostomy Continence Nurs. 2009 Nov-Dec;36(6 Suppl):S4-11
8673309 - J Am Coll Surg. 1996 Jul;183(1):61-4
19918145 - J Wound Ostomy Continence Nurs. 2009 Nov-Dec;36(6 Suppl):S12-6
10333919 - Diabetes Care. 1999 Jan;22(1):157-62
17515955 - Mol Med. 2007 Jan-Feb;13(1-2):30-9
19632603 - J Am Coll Surg. 2009 Aug;209(2):254-260.e1
15451946 - Diabetes Care. 2004 Oct;27(10):2568-9; author reply 2569
18496083 - J Wound Ostomy Continence Nurs. 2008 May-Jun;35(3):273-80
15972952 - Am J Pathol. 2005 Jul;167(1):59-69
17507982 - Nature. 2007 May 17;447(7142):316-20
9686693 - Diabet Med. 1998 Jul;15(7):539-53
17109886 - J Surg Res. 2007 Mar;138(1):141-50
References_xml – volume: 99
  start-page: 6973
  year: 2002
  end-page: 6978
  ident: CR7
  article-title: Beta-catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.102657399
– volume: 209
  start-page: 254
  year: 2009
  end-page: 260
  ident: CR11
  article-title: Surgical pathology to describe the clinical margin of debridement of chronic wounds using a wound electronic medical record
  publication-title: J Am Coll Surg
  doi: 10.1016/j.jamcollsurg.2009.04.012
– volume: 36
  start-page: S12
  issue: 6Suppl
  year: 2009
  end-page: S16
  ident: CR18
  article-title: Collagenase Santyl ointment: a selective agent for wound debridement
  publication-title: J Wound Ostomy Continence Nurs
  doi: 10.1097/WON.0b013e3181bfdd1a
– volume: 10
  start-page: 354
  year: 2002
  end-page: 359
  ident: CR14
  article-title: Debridement performance index and its correlation with complete closure of diabetic foot ulcers
  publication-title: Wound Repair Regen
  doi: 10.1046/j.1524-475X.2002.10603.x
– volume: 12
  start-page: 103
  year: 2006
  end-page: 105
  ident: CR21
  article-title: Effects of stagnation-resolving and tissue-regenerating method on wound granulation color and wound exudation of chronic lower-limber ulceration
  publication-title: Chin J Surg Integr Tradit West Med (Chin)
– volume: 447
  start-page: 316
  year: 2007
  end-page: 320
  ident: CR9
  article-title: Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding
  publication-title: Nature
  doi: 10.1038/nature05766
– volume: 35
  start-page: 273
  year: 2008
  end-page: 280
  ident: CR16
  article-title: Enzymatic wound debridement
  publication-title: J Wound Ostomy Continence Nurs
  doi: 10.1097/01.WON.0000319125.21854.78
– ident: CR3
– volume: 117
  start-page: 1219
  year: 2007
  end-page: 1222
  ident: CR10
  article-title: Cellular and molecular basis of wound healing in diabetes
  publication-title: J Clin Invest
  doi: 10.1172/JCI32169
– volume: 167
  start-page: 59
  year: 2005
  end-page: 69
  ident: CR8
  article-title: Molecular pathogenesis of chronic wounds: the role of β-catenin and c-myc in the inhibition of epithelialization and wound healing
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)62953-7
– volume: 183
  start-page: 61
  year: 1996
  end-page: 64
  ident: CR15
  article-title: Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group
  publication-title: J Am Coll Surg
– volume: 22
  start-page: 25
  year: 2009
  end-page: 27
  ident: CR19
  article-title: Maggot therapy for wound management
  publication-title: Adv Skin Wound Care
  doi: 10.1097/01.ASW.0000343730.76308.6a
– volume: 20
  start-page: 449
  year: 2004
  end-page: 451
  ident: CR5
  article-title: Attach further importance to studies on mechanism and prevention of chronic dermal ulcers
  publication-title: Chin J Traumatol (Chin)
– volume: 21
  start-page: 487
  year: 2008
  end-page: 492
  ident: CR12
  article-title: Using gene transcription patterns (bar coding scans) to guide wound debridement and healing
  publication-title: Adv Skin Wound Care
  doi: 10.1097/01.ASW.0000323563.59885.1c
– volume: 4
  start-page: 48
  year: 2005
  end-page: 50
  ident: CR22
  article-title: Clinical observation on stagnation-resolving and tissue-regenerating method in treatment of 50 cases of chronic lower-limb ulceration
  publication-title: Chin J Dermatovenerol Integr Tradit West Med (Chin)
– volume: 138
  start-page: 141
  year: 2007
  end-page: 150
  ident: CR6
  article-title: Beta-catenin signaling in fibroproliferative disease
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2006.07.026
– volume: 27
  start-page: 2568
  year: 2004
  end-page: 2569
  ident: CR1
  article-title: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.10.2568
– volume: 13
  start-page: 30
  year: 2007
  end-page: 39
  ident: CR13
  article-title: Molecular markers in patients with chronic wounds to guide surgical debridement
  publication-title: Mol Med
  doi: 10.2119/2006-00054.Vittorini
– volume: 3
  start-page: 216
  year: 2005
  end-page: 219
  ident: CR23
  article-title: Effects of Shengji Huayu Recipe and its decomposed formulas on synthesis of collagen types I and III in granulation tissue of rats in early wound healing
  publication-title: J Chin Integr Med (Chin)
  doi: 10.3736/jcim20050314
– volume: 49
  start-page: 258
  year: 2008
  end-page: 260
  ident: CR24
  article-title: Effect of stasis-resolving and muscle-regenerating therapy on apoptosis-related gene expression in granulation tissue of diabetic rat wound healing
  publication-title: J Tradit Chin Med (Chin)
– volume: 36
  start-page: S4
  issue: 6Suppl
  year: 2009
  end-page: S11
  ident: CR17
  article-title: Collagenase for enzymatic debridement: a systematic review
  publication-title: J Wound Ostomy Continence Nurs
  doi: 10.1097/WON.0b013e3181bfdf83
– volume: 22
  start-page: 157
  year: 1999
  end-page: 162
  ident: CR4
  article-title: Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings
  publication-title: Diabetes Care
  doi: 10.2337/diacare.22.1.157
– volume: 15
  start-page: 539
  year: 1998
  end-page: 553
  ident: CR2
  article-title: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis classification of diabetes mellitus provisional report of a WHO consultation
  publication-title: Diabet Med
  doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
– volume: 5
  start-page: 38
  issue: 10
  year: 2009
  ident: CR20
  article-title: Beta-catenin and transforming growth factor beta have distinct roles regulating fibroblast cell motility and the induction of collagen lattice contraction
  publication-title: BMC Cell Biol
  doi: 10.1186/1471-2121-10-38
– volume: 3
  start-page: 216
  year: 2005
  ident: 703_CR23
  publication-title: J Chin Integr Med (Chin)
  doi: 10.3736/jcim20050314
– volume: 447
  start-page: 316
  year: 2007
  ident: 703_CR9
  publication-title: Nature
  doi: 10.1038/nature05766
– volume: 4
  start-page: 48
  year: 2005
  ident: 703_CR22
  publication-title: Chin J Dermatovenerol Integr Tradit West Med (Chin)
– volume: 49
  start-page: 258
  year: 2008
  ident: 703_CR24
  publication-title: J Tradit Chin Med (Chin)
– volume: 36
  start-page: S4
  issue: 6Suppl
  year: 2009
  ident: 703_CR17
  publication-title: J Wound Ostomy Continence Nurs
  doi: 10.1097/WON.0b013e3181bfdf83
– volume: 10
  start-page: 354
  year: 2002
  ident: 703_CR14
  publication-title: Wound Repair Regen
  doi: 10.1046/j.1524-475X.2002.10603.x
– volume: 138
  start-page: 141
  year: 2007
  ident: 703_CR6
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2006.07.026
– volume: 183
  start-page: 61
  year: 1996
  ident: 703_CR15
  publication-title: J Am Coll Surg
– volume: 27
  start-page: 2568
  year: 2004
  ident: 703_CR1
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.10.2568
– volume: 15
  start-page: 539
  year: 1998
  ident: 703_CR2
  publication-title: Diabet Med
  doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
– volume: 5
  start-page: 38
  issue: 10
  year: 2009
  ident: 703_CR20
  publication-title: BMC Cell Biol
  doi: 10.1186/1471-2121-10-38
– ident: 703_CR3
– volume: 21
  start-page: 487
  year: 2008
  ident: 703_CR12
  publication-title: Adv Skin Wound Care
  doi: 10.1097/01.ASW.0000323563.59885.1c
– volume: 167
  start-page: 59
  year: 2005
  ident: 703_CR8
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)62953-7
– volume: 35
  start-page: 273
  year: 2008
  ident: 703_CR16
  publication-title: J Wound Ostomy Continence Nurs
  doi: 10.1097/01.WON.0000319125.21854.78
– volume: 209
  start-page: 254
  year: 2009
  ident: 703_CR11
  publication-title: J Am Coll Surg
  doi: 10.1016/j.jamcollsurg.2009.04.012
– volume: 13
  start-page: 30
  year: 2007
  ident: 703_CR13
  publication-title: Mol Med
  doi: 10.2119/2006-00054.Vittorini
– volume: 20
  start-page: 449
  year: 2004
  ident: 703_CR5
  publication-title: Chin J Traumatol (Chin)
– volume: 117
  start-page: 1219
  year: 2007
  ident: 703_CR10
  publication-title: J Clin Invest
  doi: 10.1172/JCI32169
– volume: 36
  start-page: S12
  issue: 6Suppl
  year: 2009
  ident: 703_CR18
  publication-title: J Wound Ostomy Continence Nurs
  doi: 10.1097/WON.0b013e3181bfdd1a
– volume: 12
  start-page: 103
  year: 2006
  ident: 703_CR21
  publication-title: Chin J Surg Integr Tradit West Med (Chin)
– volume: 99
  start-page: 6973
  year: 2002
  ident: 703_CR7
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.102657399
– volume: 22
  start-page: 157
  year: 1999
  ident: 703_CR4
  publication-title: Diabetes Care
  doi: 10.2337/diacare.22.1.157
– volume: 22
  start-page: 25
  year: 2009
  ident: 703_CR19
  publication-title: Adv Skin Wound Care
  doi: 10.1097/01.ASW.0000343730.76308.6a
– reference: 15885172 - Zhong Xi Yi Jie He Xue Bao. 2005 May;3(3):216-9
– reference: 17515955 - Mol Med. 2007 Jan-Feb;13(1-2):30-9
– reference: 12453138 - Wound Repair Regen. 2002 Nov-Dec;10(6):354-9
– reference: 15451946 - Diabetes Care. 2004 Oct;27(10):2568-9; author reply 2569
– reference: 9686693 - Diabet Med. 1998 Jul;15(7):539-53
– reference: 17109886 - J Surg Res. 2007 Mar;138(1):141-50
– reference: 17507982 - Nature. 2007 May 17;447(7142):316-20
– reference: 8673309 - J Am Coll Surg. 1996 Jul;183(1):61-4
– reference: 11983872 - Proc Natl Acad Sci U S A. 2002 May 14;99(10):6973-8
– reference: 19918145 - J Wound Ostomy Continence Nurs. 2009 Nov-Dec;36(6 Suppl):S12-6
– reference: 19632603 - J Am Coll Surg. 2009 Aug;209(2):254-260.e1
– reference: 17476353 - J Clin Invest. 2007 May;117(5):1219-22
– reference: 10333919 - Diabetes Care. 1999 Jan;22(1):157-62
– reference: 18836328 - Adv Skin Wound Care. 2008 Oct;21(10):487-92; quiz 493-4
– reference: 19918148 - J Wound Ostomy Continence Nurs. 2009 Nov-Dec;36(6 Suppl):S4-11
– reference: 19432963 - BMC Cell Biol. 2009 May 11;10:38
– reference: 18496083 - J Wound Ostomy Continence Nurs. 2008 May-Jun;35(3):273-80
– reference: 19096281 - Adv Skin Wound Care. 2009 Jan;22(1):25-7
– reference: 15972952 - Am J Pathol. 2005 Jul;167(1):59-69
SSID ssj0057605
Score 1.9734321
Snippet Objective:To observe the clinical efficacy of Chinese medicine(CM) treatment of Hongyou Ointment(红油膏) and Shengji Powder(生肌散) on diabetic...
Objective To observe the clinical efficacy of Chinese medicine (CM) treatment of Hongyou Ointment (红油膏) and Shengji Powder (生肌散) on diabetic ulcers, and...
To observe the clinical efficacy of Chinese medicine (CM) treatment of Hongyou Ointment and Shengji Powder on diabetic ulcers, and to observe the influence of...
SourceID proquest
pubmed
crossref
springer
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 261
SubjectTerms Adult
Aged
beta Catenin - metabolism
Diabetes Complications - metabolism
Diabetes Complications - therapy
Female
Humans
Immunohistochemistry
Male
Medicine
Medicine & Public Health
Medicine, Chinese Traditional
Middle Aged
Original Article
Polysaccharides, Bacterial - metabolism
Prospective Studies
Proto-Oncogene Proteins c-myc - metabolism
Single-Blind Method
Skin Ulcer - metabolism
Skin Ulcer - therapy
Wnt信号通路
中国医药
伤口愈合
皮肤溃疡
糖尿病
蛋白质
配合治疗
Title Effects of External Application of Chinese Medicine on Diabetic Ulcers and the Expressions of β-catenin,c-myc and K6
URI http://lib.cqvip.com/qk/86437A/20114/37669839.html
https://link.springer.com/article/10.1007/s11655-011-0703-5
https://www.ncbi.nlm.nih.gov/pubmed/21509668
https://www.proquest.com/docview/863428775
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1993-0402
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0057605
  issn: 1672-0415
  databaseCode: AFBBN
  dateStart: 19970301
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1993-0402
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0057605
  issn: 1672-0415
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1993-0402
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0057605
  issn: 1672-0415
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fTxQxEJ_AkRhejILgiZI--AQ02X9t9x4vBrxI4MlLjqem7XaVcPbUvTPxa_lB_EzO7G4PDGjC62Z2mnTamd90pr8CvBXG1MY7y7PCeV7YynGbEuV-JUY-dcqnLQPfxaWcTIsPMzHr73E3sds9liRbT3172S2VghrNMP3FZcrFJmwJYvPCRTzNxtH9In5u-xZTqTJO989jKfMhFUSo8HkRPn3D4f4OTPfQ5r1KaRuAzp7B0x45snFn6uew4cMOPLnoa-O78KMjIm7YomaR25ndqU_Td3ot2zeexYo6w8_d6eu1Y6u5QyzITKgYokLU0ffIhlbl71-cmqfCdThhjn_56VrBc_kCpmenH99NeP-qAne5SpYcZ6y2Wa1siXlxpkyROum8UqqWaBr0jbVwnpCXIeblMi0Ehq9RkmNq5mWe2nwPBmER_EtgWS6MyDzpEIUxlcE829qkqCtf55VyQzhYTy9GZXdDXFMaXZocIS4bQhInXLuekJzexZjrWyplspdGe2mylxZDOFr_8rVj4_ifMItW1LhnqBBigl-sGl3KnDJFhSL7nXXX2hABYVInyyEcR3Prflc3_x7q1aOkD2C7O5mm_p_XMFh-X_k3CG2W9hC2xu-vzk8P2yX9B9wr8D8
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NTtwwEB61VGq5IPoHC_3xgROtpXUS27tHhIq2heXEStws23FaBHiB7CLxWjwIz8RMEi9UtJV6jSZjyWPPfOMZfwbYktZWNnjHs8IHXrjScyeIcr-UwyC8DqJh4BsfqtGk-HEsj7t73HXqdk8lycZTP1x2E0pSoxmmv7hMuXwOL4i_igjzJ9lOcr-In5u-RaF0xun-eSpl_kkFESr8msaflzjc74HpCdp8UiltAtDeKqx0yJHttKZ-Dc9CfAMvx11t_C1ct0TENZtWLHE7s0f1afpOr2WHOrBUUWf4uT19PfFsfuYRCzIbS4aoEHV0PbKxUXl3y6l5Kp7Er8zz8xvfCO6rdzDZ-3a0O-Ldqwrc57o_48NMVC6rtBtgXpxpWwivfNBaVwpNg76xkj4Q8rLEvDwQhcTwNeznmJoFlQuXv4elOI1hHViWSyuzQDpkYW1pMc92rl9UZajyUvsebC6mF6OyPyWuKYMuTQ0Rl_Wgnybc-I6QnN7FODMPVMpkL4P2MmQvI3uwvfjlomXj-JcwS1Y0uGeoEGJjmM5rM1A5ZYoaRdZa6y60IQLCpE4NevAlmdt0u7r--1Ab_yX9GV6NjsYH5uD74f4mLLen1NQL9AGWZlfz8BFhzsx9apb1PbdX8Zc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fTxQxEJ8gJMQXovjvRKEPPqkN191te_dI1AuCEB-8hLem7bZIxB64dyZ-LT-In8mZ3e2BQU143cxOk_6m7Uxn-huAF9LaaIN3vKh84JWrPXeCKPdrOQ7C6yBaBr6jY7U_rQ5O5Enf57TJ1e45Jdm9aSCWpjTfvajj7tXDN6EkFZ1hKIwmy-UdWKuIJwENelrs5a0Yfem2hlEoXXB6i57Tmn9TQeQKn2fp9BKH_vOQuuF53siatofR5B5s9F4k2-tgvw8rIW3C-lGfJ38A3ztS4obNIss8z-xarpq-U-fs0ASWs-sMP3c3sWeeLc49-oXMppqhh4g6-nrZ1Kr89ZNTIVU6S6-Z519_-FbwUD2E6eTdpzf7vO-wwH2ph3M-LkR0RdRuhDFyoW0lvPJBax0VwoT7ZJQ-kBdmiYV5JCqJR9l4WGKYFlQpXPkIVtMshSfAilJaWQTSIStra4sxt3PDKtYhlrX2A9haTi-e0P4L8U4Z3N7UGH20AQzzhBvfk5NTj4xzc0WrTHgZxMsQXkYO4OXyl4uOmeN_wiyjaHD9UFLEpjBbNGakSooaNYo87tBdakN7wgBPjQbwKsNt-hXe_Huop7eS3oH1j28n5sP748MtuNtdWFNZ0DNYnX9bhOfo8czddmvVvwGz4_XT
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+external+application+of+Chinese+medicine+on+diabetic+ulcers+and+the+expressions+of+%CE%B2-catenin%2C+c-myc+and+K6&rft.jtitle=Chinese+journal+of+integrative+medicine&rft.au=Li%2C+Fu-Lun&rft.au=Deng%2C+Hui&rft.au=Wang%2C+Hong-Wei&rft.au=Xu%2C+Rong&rft.date=2011-04-01&rft.issn=1672-0415&rft.volume=17&rft.issue=4&rft.spage=261&rft_id=info:doi/10.1007%2Fs11655-011-0703-5&rft_id=info%3Apmid%2F21509668&rft.externalDocID=21509668
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86437A%2F86437A.jpg